← Back to catalogue
PIVKA-II Detection Kit (Chemiluminescence Immunoassay)
EUDAMEDClass IVD General (EU MDR)
Ref 3010686Model 1×100 Tests/kitRef 3010666Model 1×50 Tests/kitRef 3014256Model 2×50 Tests/kit
Identity
- Trade Name
- PIVKA-II Detection Kit (Chemiluminescence Immunoassay) EUDAMED
- Device Name
- PIVKA-II Detection Kit (Chemiluminescence Immunoassay) EUDAMED
- Model / Reference
- 1×100 Tests/kit EUDAMED3010686 EUDAMED1×50 Tests/kit EUDAMED3010666 EUDAMED2×50 Tests/kit EUDAMED3014256 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06925794571434 EUDAMED06925794571427 EUDAMED06942202224317 EUDAMED
- Basic UDI-DI
- B-06925794571434 EUDAMEDB-06925794571427 EUDAMEDB-06942202224317 EUDAMED
- EMDN Code
- W0102030199 CANCER ANTIGENS - OTHER EUDAMED
Classification
- Device Class
- Class IVD General EUDAMED
- Market of Registration
- Austria EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
Yes
EUDAMED
Animal Tissues
Yes
EUDAMED
Microbial Substances
No
EUDAMED
Reagent
Yes
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
Yes
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
PIVKA-II Detection Kit (Chemiluminescence Immunoassay) by Dirui Industrial Co., Ltd — Class IVD General — IVDD — listed in EUDAMED
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDD | B-06925794571434 | Class IVD General | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Dirui Industrial Co., Ltd
- EUDAMED SRN
- CN-MF-000001891
- Authorised Representative
- Emergo Europe B.V. NL-AR-000000116
Sources (3)
- EUDAMED 45c31985-f26f-4e6d-b253-fbc75342a419 61 fields · synced Jul 26, 2026
- EUDAMED b69f9980-3d6e-4f94-87bc-9ec644203e98 61 fields · synced May 17, 2026
- EUDAMED 56503cf8-54c5-431a-a76c-d4de35048850 61 fields · synced May 17, 2026